[144] ORMAT TECHNOLOGIES, INC. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for ORA (Ormat Technologies, Inc.) reporting a proposed sale of common stock by an insider. The notice lists 9,343 shares offered for sale through Morgan Stanley Smith Barney LLC with an aggregate market value of $871,810.28 and indicates approximately 60,723,470 shares outstanding. The filing details that the securities were acquired mostly as restricted stock and performance shares on various dates from 2023 to 2025. The filer also reported a sale on 08/22/2025 of 7,066 shares generating $669,220.86 in gross proceeds. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Transparent disclosure of proposed insider sale including broker, share counts, and aggregate value
• Origin of shares disclosed (restricted stock and performance shares) showing these are compensation-related
• Previous recent sale disclosed (7,066 shares on 08/22/2025 for $669,220.86), adding context to insider trading activity

Negative

• Insider selling of company stock could be perceived negatively by some investors despite disclosure

Insights

Financial Analyst

TL;DR: Insider intends to sell a modest block of ORA shares; transaction is disclosed and appears routine.

The filing shows a proposed sale of 9,343 common shares through a broker with an aggregate market value of $871,810.28. Acquisitions listed are primarily restricted stock and performance shares awarded between 03/01/2023 and 03/21/2025, indicating these are insider compensation shares being liquidated. A prior sale on 08/22/2025 of 7,066 shares for $669,220.86 is disclosed, demonstrating recent insider liquidity. From a financial perspective, the disclosure is transparent and provides clear provenance of the shares sold; the size of the blocks relative to total outstanding shares appears limited based on the figures provided.

Corporate Governance Expert

TL;DR: The Form 144 disclosure follows regulatory requirements and signals routine insider selling from awarded equity.

The table documents that the securities originated as restricted stock and performance awards from the issuer, demonstrating standard equity compensation vesting and monetization. The filer attests there is no undisclosed material adverse information, and the use of a broker (Morgan Stanley Smith Barney LLC) is typical for such transactions. No indications of unusual trading plans or exceptions are present in the provided text. From a governance standpoint, the filing satisfies disclosure norms but does not provide further context on the insider's reasons for sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	9343	871810.28	60723470	09/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2025	Restricted Stock	Issuer			3070	03/01/2025	Not Applicable
Common	03/21/2024	Restricted Stock	Issuer			1063	03/21/2024	Not Applicable
Common	03/01/2024	Restricted Stock	Issuer			778	03/01/2024	Not Applicable
Common	03/01/2023	Restricted Stock	Issuer			447	03/01/2023	Not Applicable
Common	03/21/2025	Restricted Stock	Issuer			1063	03/21/2025	Not Applicable
Common	03/01/2025	Performance Shares	Issuer			2084	03/01/2025	Not Applicable
Common	05/12/2023	Restricted Stock	Issuer			838	05/12/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ASSAF GINZBURG 6884 Sierra Center Pkwy Reno NV 89511	Common	08/22/2025	7066	669220.86

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Form 144 for ORA report for sale?

The notice reports 9,343 shares of ORA common stock to be sold through Morgan Stanley Smith Barney LLC with an aggregate market value of $871,810.28.

Who acquired the shares being sold and how were they acquired?

The securities were acquired from the issuer as restricted stock and performance shares on dates between 03/01/2023 and 03/21/2025, with specific amounts listed in the filing.

Has the seller made any recent sales of ORA shares?

Yes. The filing shows a sale by Assaf Ginzburg of 7,066 shares on 08/22/2025 for $669,220.86 in gross proceeds.

Which broker is handling the proposed sale?

The proposed sale is to be executed by Morgan Stanley Smith Barney LLC, Executive Financial Services located at 1 New York Plaza, 8th Floor, New York, NY.

Does the filer assert any undisclosed material information about the issuer?

The filer represents by signature that they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.